Literature DB >> 17016935

Cost assessment and price setting of inpatient care in The Netherlands. the DBC case-mix system.

J B Oostenbrink1, F F H Rutten.   

Abstract

In February 2005, a case-mix system based on 'diagnosis treatment combinations' (DBCs) was introduced in The Netherlands for the registration and reimbursement of hospital and medical specialist care. This paper describes the characteristics of the DBC system and how it is used for the reimbursement of hospitals. Prices for reimbursement are either based on fixed tariffs ('list A') or negotiated between health insurers and hospitals ('list B') and are partly based on information about unit costs of health care services. Because the DBC system is still under development we will describe the current situation (March 2006), but also focus on the most likely future developments.

Mesh:

Year:  2006        PMID: 17016935     DOI: 10.1007/s10729-006-9096-y

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  3 in total

1.  Managed competition and consumer price sensitivity in social health insurance.

Authors:  Frederik T Schut; Wolter H J Hassink
Journal:  J Health Econ       Date:  2002-11       Impact factor: 3.883

2.  Linking nursing care to medical diagnoses: heterogeneity of patient groups.

Authors:  Lisanne van Beek; William T F Goossen; Willem A van der Kloot
Journal:  Int J Med Inform       Date:  2005-08-11       Impact factor: 4.046

Review 3.  The "health benefit basket" in the Netherlands.

Authors:  Elly A Stolk; Frans F H Rutten
Journal:  Eur J Health Econ       Date:  2005-12
  3 in total
  16 in total

1.  Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries.

Authors:  Jonas Schreyögg; Tom Stargardt; Oliver Tiemann; Reinhard Busse
Journal:  Health Care Manag Sci       Date:  2006-08

2.  Explaining length of stay variation of episodes of care in the Netherlands.

Authors:  Siok Swan Tan; Leona Hakkaart-van Roijen; B Martin van Ineveld; W Ken Redekop
Journal:  Eur J Health Econ       Date:  2012-10-21

3.  Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Authors:  Rawa Kamaran Ismail; Jesper van Breeschoten; Silvia van der Flier; Caspar van Loosen; Anna Maria Gerdina Pasmooij; Maaike van Dartel; Alfons van den Eertwegh; Anthonius de Boer; Michel Wouters; Doranne Hilarius
Journal:  J Med Internet Res       Date:  2022-06-23       Impact factor: 7.076

4.  Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

Authors:  Marianne van der Mark; Roel Vermeulen; Peter C G Nijssen; Wim M Mulleners; Antonetta M G Sas; Teus van Laar; Hans Kromhout; Anke Huss
Journal:  Int Arch Occup Environ Health       Date:  2014-06-18       Impact factor: 3.015

5.  Is the quality of data in an electronic medical record sufficient for assessing the quality of primary care?

Authors:  Pashiera Barkhuysen; Wim de Grauw; Reinier Akkermans; José Donkers; Henk Schers; Marion Biermans
Journal:  J Am Med Inform Assoc       Date:  2013-10-21       Impact factor: 4.497

6.  Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany.

Authors:  Matthias Vogl
Journal:  Health Econ Rev       Date:  2012-08-30

7.  Cost-effectiveness of intensive inpatient treatments for severely obese children and adolescents in the Netherlands; a randomized controlled trial (HELIOS).

Authors:  Sabine Makkes; Jutka Halberstadt; Carry M Renders; Judith E Bosmans; Olga H van der Baan-Slootweg; Jacob C Seidell
Journal:  BMC Public Health       Date:  2011-06-30       Impact factor: 3.295

8.  Basing care reforms on evidence: the Kenya health sector costing model.

Authors:  Steffen Flessa; Michael Moeller; Tim Ensor; Klaus Hornetz
Journal:  BMC Health Serv Res       Date:  2011-05-27       Impact factor: 2.655

9.  Value Driven Outcomes (VDO): a pragmatic, modular, and extensible software framework for understanding and improving health care costs and outcomes.

Authors:  Kensaku Kawamoto; Cary J Martin; Kip Williams; Ming-Chieh Tu; Charlton G Park; Cheri Hunter; Catherine J Staes; Bruce E Bray; Vikrant G Deshmukh; Reid A Holbrook; Scott J Morris; Matthew B Fedderson; Amy Sletta; James Turnbull; Sean J Mulvihill; Gordon L Crabtree; David E Entwistle; Quinn L McKenna; Michael B Strong; Robert C Pendleton; Vivian S Lee
Journal:  J Am Med Inform Assoc       Date:  2014-10-16       Impact factor: 4.497

10.  A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking.

Authors:  Marianne van der Mark; Peter C G Nijssen; Jelle Vlaanderen; Anke Huss; Wim M Mulleners; Antonetta M G Sas; Teus van Laar; Hans Kromhout; Roel Vermeulen
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.